Templin Barry L sold $10K of PRCT
Templin Barry L (EVP, Chief Technology Officer) sold 358 shares of PROCEPT BioRobotics Corp (PRCT) at $28.48 on 2026-06-08.
How this was made
The 30-second read
Why it matters
The newest fact is the CTO’s open-market sale of 358 shares at $28.4790 on 2026-06-08, with holdings after the trade of 68,953 shares and no pre-arranged 10b5-1 plan.
Market read
Traders may note the insider sale as a sentiment datapoint, but the small dollar amount limits tradable impact absent other catalysts.
What to watch
The article provides only the sale details (size, price, holdings) and no context on compensation, tax obligations, or prior planned sales cadence.
Background
The article is an SEC EDGAR Form 4 insider transaction disclosure for Procept BioRobotics (PRCT).
Ticker impact
Procept BioRobotics CTO sold 358 shares in an open-market transaction reported on SEC Form 4 (no 10b5-1 plan).
Low likelihood of a sustained price move; any reaction would likely be short-lived unless followed by additional insider selling or new company catalysts.
The filing is primary-source (Form 4) and the sale is real, but the transaction value (~$10.2k) is small and does not indicate a corporate event or guidance change.
Market effects
No direct sector read-through; this is an individual insider transaction without disclosed operational/regulatory impact.
None indicated.
None indicated.
Counterpoint
Insider sales can be routine for diversification/taxes; the absence of a 10b5-1 plan does not necessarily imply bearish expectations.
Key entities
- issuerPROCEPT BioRobotics Corp
Company whose insider transaction was disclosed via SEC Form 4.
- insiderTemplin Barry L
EVP, Chief Technology Officer who sold shares.